Atria Wealth Solutions Inc. Has $1.31 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Atria Wealth Solutions Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,548 shares of the exchange traded fund’s stock after buying an additional 2,822 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,310,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $141,284,000. Mirae Asset Securities USA Inc. boosted its stake in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the last quarter. Assetmark Inc. increased its holdings in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Finally, Sivik Global Healthcare LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $29,640,000.

SPDR S&P Biotech ETF Stock Down 1.1 %

Shares of NYSEARCA:XBI opened at $91.70 on Monday. The business’s 50 day moving average is $91.36 and its 200 day moving average is $96.00. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market cap of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.